THE IMPACT OF SUBSPECIALTY TRAINING ON THE MANAGEMENT OF ADVANCED OVARIAN-CANCER

被引:216
作者
EISENKOP, SM
SPIRTOS, NM
MONTAG, TW
NALICK, RH
WANG, HJ
机构
[1] WOMENS CANC CTR,PALO ALTO,CA
[2] LOS ANGELES CTR GYNECOL ONCOL,LOS ANGELES,CA
[3] UNIV CALIF LOS ANGELES,SCH PUBL HLTH,DEPT BIOMATH,LOS ANGELES,CA 90024
关键词
D O I
10.1016/0090-8258(92)90107-T
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A retrospective study was conducted to determine the influence of subspecialty training in gynecologic oncology as well as several other covariates on the feasibility, operative mortality, and survival benefits of cytoreductive surgery for 263 patients with stages IIIC and IVA epithelial ovarian cancer. Covariates most predictive of an optimal (≤ 1 cm) cytoreductive outcome were the diameter of the largest metastases before cytoreduction (≤ 10 cm vs > 10 cm, P < 0.001) and the specialty training of the physicians present at surgery (gynecologic oncologists vs other, P < 0.001). Age influenced operative mortality most (<60 vs ≥60, P < 0.001). Covariates found to most significantly influence survival time include the specialty training of the physicians present at surgery (gynecologic oncologists vs other, P < 0.0001), cytoreductive outcome (complete vs optimal, P = 0.001, optimal vs suboptimal, P < 0.0001), grade of tumor (grade 1 vs grades 2 and 3, P = 0.01), and pelvic disease status (frozen pelvis vs mobile primary tumor, P = 0.03). We conclude that patients with advanced epithelial ovarian cancer should undergo aggressive cytoreductive surgery by gynecologic oncologists, with the objective to remove all macroscopic disease. Subsequent treatment with platinum-based chemotherapy offers the best chance for long-term survival or cure. © 1992.
引用
收藏
页码:203 / 209
页数:7
相关论文
共 17 条
[1]   IMPROVED PROGNOSIS OF OVARIAN-CANCER IN THE NETHERLANDS DURING THE PERIOD 1975-1985 - A REGISTRY-BASED STUDY [J].
BALVERTLOCHT, HR ;
COEBERGH, JWW ;
HOP, WCJ ;
BROLMANN, HAM ;
CROMMELIN, M ;
VANWIJCK, DJAM ;
VERHAGENTEULINGS, MTCIJ .
GYNECOLOGIC ONCOLOGY, 1991, 42 (01) :3-8
[2]   LOWER URINARY-TRACT RESECTION AS PART OF CYTOREDUCTIVE SURGERY FOR OVARIAN-CANCER [J].
BEREK, JS ;
HACKER, NF ;
LAGASSE, LD ;
LEUCHTER, RS .
GYNECOLOGIC ONCOLOGY, 1982, 13 (01) :87-92
[3]   DEBULKING SURGERY - DOES IT INCREASE THE QUALITY OF SURVIVAL [J].
BLYTHE, JG ;
WAHL, TP .
GYNECOLOGIC ONCOLOGY, 1982, 14 (03) :396-408
[4]   ELECTROSURGICAL DEBULKING OF OVARIAN-CANCER - A NEW TECHNIQUE USING THE ARGON BEAM COAGULATOR [J].
BRAND, E ;
PEARLMAN, N .
GYNECOLOGIC ONCOLOGY, 1990, 39 (02) :115-118
[5]   PELVIC LYMPHADENECTOMY IN OPERATIVE TREATMENT OF OVARIAN-CANCER [J].
BURGHARDT, E ;
PICKEL, H ;
LAHOUSEN, M ;
STETTNER, H .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (02) :315-319
[6]   ASSESSMENT OF MORBIDITY AND MORTALITY IN PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN-CARCINOMA [J].
CHEN, SS ;
BOCHNER, R .
GYNECOLOGIC ONCOLOGY, 1985, 20 (02) :190-195
[7]   STAGE-III EPITHELIAL OVARIAN-CANCER - THE ROLE OF MAXIMAL SURGICAL REDUCTION [J].
DELGADO, G ;
ORAM, DH ;
PETRILLI, ES .
GYNECOLOGIC ONCOLOGY, 1984, 18 (03) :293-298
[8]   DEBULKING SURGERY FOR OVARIAN-CANCER WITH THE CAVITRON ULTRASONIC SURGICAL ASPIRATOR (CUSA) - A PRELIMINARY-REPORT [J].
DEPPE, G ;
MALVIYA, VK ;
MALONE, JM .
GYNECOLOGIC ONCOLOGY, 1988, 31 (01) :223-226
[9]  
DISAIA PJ, 1989, CLIN GYNECOLOGIC ONC
[10]  
EISENKOP SM, 1992, OBSTET GYNECOL, V78, P879